Recent statistics from the NHS have highlighted an increase in prescribed medicine for attention deficit hyperactivity disorder (ADHD) over the past year,
NICE has followed through on plans to make a series of digital therapeutics (DTx) for adults with anxiety disorders or depression in England, although it acknowledges more
UK cost-effectiveness agency NICE has said that guided, self-help digital cognitive behavioural therapy (CBT) apps can be used by the NHS for initial treatment of children
In this bonus interview from Frontiers Health 2022, provided by our partners at Healthware, pharmaphorum Founder Paul Tunnah chats with Woebot Health Chief Business Officer Monique Levy abo
Rumours that Sanofi was in discussion with private equity groups over the sale of its consumer health business Opella have been confirmed – at least partially.